Thomas Beetham - Insider Trading & Ownership

Entity
Individual
Location
C/O Kiniksa Pharmaceuticals, Ltd., Clarendon House, 2 Church Street, Hamilton, Bermuda
Summary
The estimated net worth of Thomas Beetham is at least $379K dollars as of September 30, 2024. Thomas Beetham is the Title: Chief Legal Officer and Secretary of Magenta Therapeutics, Inc. and owns shares of Dianthus Therapeutics, Inc. /DE/ (DNTH) stock worth about $239K. Thomas Beetham is the Chief Operating Officer of Viridian Therapeutics, Inc.\DE and owns shares of Viridian Therapeutics, Inc.\DE (VRDN) stock worth about $140K.
All Insider Reports
All Insider Reports

Ownership of Thomas Beetham

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DNTH Dianthus Therapeutics, Inc. /DE/ Title: Chief Legal Officer and Secretary $239K Nov 30, 2022
VRDN Viridian Therapeutics, Inc.\DE Chief Operating Officer $140K +$117K +500% Sep 27, 2024

Insider Transactions Reported by Thomas Beetham:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.